Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
Giuseppe Di Lorenzo(Saint Camillus International University of Health and Medical Sciences), Sabino De Placido, Vincenzo Montesarchio(CTO Hospital), Corrado Ficorella(University of L'Aquila), Antonio Giordano(University of Siena), Giacomo Cartenì(Ospedale Antonio Cardarelli), Mimma Rizzo(University of Pavia), Riccardo Autorino(Rush University Medical Center), Michael S. Ewer, Carmela Romano(Centro di Riferimento Oncologico della Basilicata), Mario Giuliano(Regione Campania), A. Gonnella(University of Naples Federico II), Gianni Bruni(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Enrico Ricevuto(University of L'Aquila), Michele Aieta(Centro di Riferimento Oncologico della Basilicata), Cosimo De Nunzio(Azienda Ospedaliera Sant'Andrea), Marianna Tudini(University of L'Aquila)
Cited by 205
Related Papers
Curcumin and Cancer
|Nutrients|2019|977
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Role of p53 in the Regulation of Cellular Senescence
|Biomolecules|2020|605
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413